News

Take Action For The International Thalassaemia Day 2021

Take Action For The International Thalassaemia Day 2021

INTERNATIONAL THALASSAEMIA DAY 2021 – 8 MAY  “Addressing Health Inequalities Across the Global Thalassaemia Community“ Each year, individuals around the globe band together for one day of pure and empowering…
Hemanext® Inc. Receives CE Mark Certification For Innovative Red Blood Cell (RBC) Processing & Storage System

Hemanext® Inc. Receives CE Mark Certification For Innovative Red Blood Cell (RBC) Processing & Storage System

Hemanext Inc. announced today it has received a CE Certificate of Conformity for the CE Mark for its Hemanext ONE Red Blood Cell (RBC) Processing and Storage System, allowing the…
The International Thalassaemia Day 2021 Official Page is Now Live!

The International Thalassaemia Day 2021 Official Page is Now Live!

INTERNATIONAL THALASSAEMIA DAY 2021 – 8 MAY  “Addressing Health Inequalities Across the Global Thalassaemia Community“ Visit the International Thalassaemia Day page, now LIVE on TIF website, to find out why…
TIF Presents Its Newly Launched SCD Educational Course for Healthcare Professionals On 9 April

TIF Presents Its Newly Launched SCD Educational Course for Healthcare Professionals On 9 April

TIF is delighted to announce the organisation of a Virtual Presentation Event of the ‘TIF Sickle Cell Disease Educational Course for Healthcare Professionals’ – an online course providing comprehensive information…
Blood Donors’ COVID-19 Antibodies: Do They Have A Positive Significance for Blood Recipients?

Blood Donors’ COVID-19 Antibodies: Do They Have A Positive Significance for Blood Recipients?

According to recent data released by the American Red Cross, in the first week of March 2021 more than 20% of blood donations from unvaccinated people in the US had…
COMING UP: New TIF Webinar On “COVID-19 Vaccinations & Patients With Haemoglobin Disorders“

COMING UP: New TIF Webinar On “COVID-19 Vaccinations & Patients With Haemoglobin Disorders“

TIF is delighted to inform you that a Special Webinar on ‘’COVID-19 Vaccinations & Patients with Haemoglobin Disorders’’ will take place on Wednesday, 31 March 2021, at 14:30-16:00 EEST/12:30-14:00 GMT.…
A Head-to-Head Comparison of BMT, Gene Therapy & Gene Editing Through A Brand New TIF Infographic

A Head-to-Head Comparison of BMT, Gene Therapy & Gene Editing Through A Brand New TIF Infographic

The expansion of management options and therapies for patients with thalassaemia is nowadays a reality, thanks to the application of new, revolutionary scientific procedures. However, patients‘ understanding on the distinct…
Out Now: The Latest Issue of TIF’s COVID-19 Vaccinations Update

Out Now: The Latest Issue of TIF’s COVID-19 Vaccinations Update

Everything you need to know about the different COVID-19 vaccines, both already available and developing, in one place! Discover our newly updated Guide ”Vaccinations & Therapeutic Drugs for COVID-19”, containing a…
Sickle Cell Disease Patients‘ Views on Oxbryta

Sickle Cell Disease Patients‘ Views on Oxbryta

OXBRYTA (voxelotor) is a prescription medicine used for the treatment of sickle cell disease (SCD) and constitutes the first aproved treatment that directly inhibits sickle hemoglobin polymerization, the root cause…
Schaltfläche "Zurück zum Anfang"